The most common treatment-related AEs was anemia (23.29%), followed by leukopenia (21.43%), neutropenia (21.43%), thrombocytopenia (14.60%), and elevated alanine aminotransferase (ALT) or aspartate transaminase (AST) (9.63%). The gene discussed is GPT; the disease is anemia.